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DESCRIPTION OF METHODS TO COLLECT
EVIDENCES
Periodic meetings were carried out to elaborate the text,
including the relevant bibliographic citations provided by
the official committee members designated by the Brazilian
Society of Cardiovascular Surgery Board of Directors. The
members, divided into working groups, supplemented their
contribution, corrections and recommendations accepted
based on a consensus, what allowed editing the preliminary
text from a basic reference text. In different moments, we
sought after cross-references and more relevant related
papers,t to edit the texmendtionsiovascular Surgery Board
of Directors such as meta-analyses, systematic reviews,
and classic multicentric studies. It was attempted to suggest
relevant studies written by Brazilian authors, especially
those published by the Brazilian Journal of Cardiovascular
Surgery and the Brazilian Archives of Cardiology, official
publication organs of the Brazilian cardiology. This
guideline is the original version of the abovementioned
consensus. It was adapted to fit the format suggested by
the Technical Committee of the Project Guidelines of the
Brazilian Medical Association and the Federal Council of
Medicine.
DEGREE OF RECOMMENDATION AND STRENGTH
OF THE EVIDENCE
A: Large randomized clinical trails and meta-analyses.
B: Well-designed observational and clinical trials.
C: Case Reports and Clinical cases series.
D: Publications based on consensus and expert
opinions.
OBJECTIVES
To provide basic information to recognize the different
diseases of abdominal and thoracic aorta;
To allow the early identification of the entities involving
the aorta that represent surgical emergencies;
To describe the surgical and endovascular treatment options
to the diverse segments of abdominal and thoracic aorta;
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ascending aortic is that surgical intervention must be
immediate aiming mainly at avoiding rupture and death by
cardiac tamponade. Additionally, the second endpoint aims
at repairing aortic regurgitation when present; avoiding
myocardial ischemia; excluding the site of tunica intima
laceration, and re-directing the flow through the true lumen
towards the supra-aortic branches and to the descending
aorta [1-7] (D).
In the choice of the surgical reconstruction technique,
three questions must be taken into account: 1. – Which are
the diameter and the condition of the aortic root and sinus
(sinus of Valsalva) at the moment of the intervention, and if
it is possible, prior to the acute event?; 2. – Which is the
condition of the aortic valve?; 3. – Is there any extent or
existence of injury to the tunica intima of the transverse
arch? (aortic arch)
If the diameters of the ascending aorta and of the aorta
root are normal and if there is no misalignment of the aortic
valve commissural plane nor there is any distortion of the
openings of coronary sinuses (coronary ostia), the repair
usually involves the use of a straight Dacron graft
anastomosed near to the aortic sinotubular junction. If there
is loss of support of one or more commissures in the aortic
valve, they should be resuspended during the repair of the
commissural angles before the insertion of the straight graft.
However, if it is impossible to repair the aortic insufficiency
by valvoplasty or if the aortic valve is bicuspid, the
replacement must be performed using prosthesis before
the supra-commissural implant of the graft [6-8], although
some authors report success with the repair of bicuspids
valves [9].
The conventional approach to surgical repair of type-A
dissections is median sternotomy with the CPB circuit
established from cannulation of the right atrium (RA) and
the femoral artery, generally utilizing moderate hypothermia
between 28 ºC to 32 ºC. Recently, the perfusion route
through the axillary artery has been proposed by many
centers with potential advantages compared to the femoral
artery.
When aortic dissection occurs in a previously dilated
ascending aorta and/or aortic root, or in patients with
annulus-aortic ectasia associated or not with Marfan’s
syndrome, the surgical repair necessarily requires the
replacement of the aortic valve, the portion of sinotubular
junction and the aortic sinus (sinus of Valsalva), and the re-
implantation of the openings of coronary sinuses (coronary
ostia) using a valvar prosthesis of composite graft and a
Dacron mesh, known as a valved tube [10,11] (B).
In the technique originally described by Bentall & De
Bono [12], the openings of coronary sinues (coronary ostia)
are included in the ascending portion of the Dacron tube
by means of direct anastomoses performed after valve
implantation (B). The significant incidence of late
To emphasize the long-term requirements to control the
atherosclerosis risk factors and the periodic follow-up
through imaging methods in all patients surgically managed
due to aortic diseases
INTRODUCTION
However the advances in diagnostic examinations, in
monitoring and hemodynamic support methods and in the
surgical repair techniques that have occurred over the last
few years, aorta diseases are still a significant cause of
cardiovascular mortality and morbidity and a continuous
challenge for cardiologists and surgeons.
While in cases of acute dissections (AD) the consensus
regarding the requirement of immediate surgery may has
bee established, at least, three decades ago, the correct
moment to intervene in degenerative diseases, which
determine the asymptomatic dilation of the ascending aorta
as well as the management of the aortic root and the aortic
valve, in the ascending aorta diseases is still under
discussion and has been the subject of a number of recent
publications.
When the transverse arch is involved, the controversies
are focused on the choice of the best method of cerebral
protection among the hypothermic cardiocirculatory arrest,
venous retrograde perfusion, selective cerebral perfusion,
and more recently the anterograde perfusion through
subclavian-axillary axis, and in the definition of when and
to what extent the arch must be included in reconstruction.
In the treatment of the descending aorta and
thoracicoabdominal diseases, spinal cord ischemia is still
the main concern, with variable but significant involvement,
in the different approaches described. This was one
motivation for the development of self-expanding stents.
Additionally, in cases of degenerative aneurysms, in the light
of the results from recent studies on the prediction of
dissection or rupture rates, the decision of intervention based
exclusively on the diameter is being replaced by more
individualized decisions, including factors such as age, co-
morbidities and outcomes of the surgical team, among others.
Concerning abdominal aorta, the classic indication for
surgical repair of asymptomatic infra-renal aneurysms,
larger than 5 cm in diameter, may be modified by the results
of recent European and North-American trials. Similarly,
the experience with endoluminal exclusion by using
recovered prostheses – stents, described in many studies
comparing this technique to the open surgery has been the
subject of discussions and it is far away from a consensus.
ACUTE AORTIC DISSECTIONS
Acute Type-A Dissections
The first endpoint involving dissections of the
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pseudoaneurysms associated with the difficulty of direct
reimplantation of the coronary arteries, in cases in which
the dilation of the aortic sinus (sinus of Valsalva) are not so
important, supports a modification proposed by
Kouchoukos et al. [13] in which the openings of coronary
sinuses (coronary ostia) are excised and implanted in the
tube in the form of buttons (B); this technique denominated
‘button Bentall’ has presented low in-hospital mortality and
a lower probability of late events [14-16] (B). Alternatively,
the modification proposed by Cabrol et al. [17] in which a
PTFE graft is connected to the ascending portion of the
Dacron tube and anastomosed end-to-end to the openings
of coronary sinuses (coronary ostia) may be useful in
elderly patients, in surgical reoperations, or in cases in
which there is a necessity of a very complex reconstruction
of the other segments of the thoracic aorta (C).
Alternatively, stentless biological valves also can be
used to reconstruct the aortic root [16] (B).
The utilization of autograft or homograft of pulmonary
valve for the reconstruction of the aortic root, although
recommended by some authors [18-21] (B), has shown a
high incidence of reoperations due to delayed degeneration
[22] (B) and must be used in specific cases, especially in
elderly patients with or without associated endocarditis
[23] (D).
Recently, techniques of preservation and remodeling of
the aortic valve and the aortic root have been suggested
by authors including David & Feindel [24] and Sarsam &
Yacoub [11]. In these techniques, the openings of coronary
sinuses (coronary ostia) are excised and the portion of
sinotubular junction is trimmed between 3 and 5 mm above
the annulus, maintaining the cuspids and the insertion line
of the commissural angles intact; a line of individual sutures
using Teflon pledgets strength the remaining annulus-aortic
junction, which is anastomosed to the Dacron graft; and
finally, the coronary buttons are re-implanted similarly to
the Bentall button technique (B). Because the remodeling
techniques are more complex and generally require more
time than others which use valved tubes, they must be
employed by very experienced surgeons in elective
situations, leaving procedures that use composite grafts
as is recommended in annulus-aortic ectasia [23] (D). When
the occasionally delamination of the aortic wall affects the
openings of coronary sinuses (coronary ostia) preventing
satisfactory reconstruction, the alternative is limited to the
use of arterial graft(s) or saphenous vein graft(s) [23] (D).
In type-A dissections, for a better hemostasis of the
proximal and distal sutures, Teflon sheets and tissue
adhesives, such as the gelatin-resorcine-formol biological
glue (GRF) or both can be used; traditionally, the leaflets
separated by a false lumen are joined by a suture line which
includes a Teflon sheet inserted between the leaflets or
inserted as an external reinforcement. Even though there is
no consensus concerning the benefit of the biological
adhesives and this product has not yet been approved to
be used in the USA, the GRF is recommended by many
authors, as an adjuvant technique or in isolation [25] (C).
With the same purpose and now with the recent approval
for clinical use in the USA the Cryolife Bioglue adhesive
can be used.
Despite of the excellent surgical results of some groups
that have reported a in-hospital mortality between 6% and
12% [3,4,6,7,16,26-28], the International Registry of Acute
Aortic Dissection [29], in a retrospective survey of 464
cases of acute aortic dissections attended in 12 reference
centers in the USA between 1996 and 1998 showed a 26%-
surgical mortality in acute type-A dissections, a level closer
to the average in our setting (B).
When the aortic dissection involves the aortic arch
(transverse arch), the discussion regarding the different
approaches proposed usually is focused on: 1) when to
include the aortic arch in the surgical repair?; 2) how and to
what extent to reconstruct it?; and 3) what is the best method
of cerebral protection to be employed?
It is generally accepted that when the tunica intima injury
does not affect the into of the aortic arch (transverse arch),
it can be repaired through an open approach (without
clamping), holding the leaflets of the aortic wall together,
anastomosing the ascending aorta graft, and redirecting
the flow to the true lumen, a technique described as hemi-
arch repair [30-36] (D). However, around 10% to 20% of the
aortic dissections, the tunica intima injury occur into the
transverse portion of the aortic arch, making the complete
reconstruction indispensable including the reimplantation
of the supra-aortic trunks, as a block or individually. This
decision making is frequently difficult, as the morbidity
and mortality rates of total repair of the arch seem to be
substantially higher than hemi-arch repair because of the
necessary longer period of time of the cardiocirculatory
arrest (CCA) and the more intense hypothermia level, which
means a significant incidence of permanent brain injury
and bleeding due to dyscrasia. In a historical series of the
Texas Heart Institute between 1976 and 1982, 60 cases of
aortic dissection involving the arch  using hypothermic
CCA, Livesay et al. [37] reported re-intervention rates for
bleeding and postoperative stroke of 19% and 10%
respectively (C).
In the recent experience of the Mount Sinai Medical
Center Group, total replacement of the aortic arch
(transverse arch) was employed in 11 out of 19 cases of
type-A aortic dissection, with a mean CCA time under deep
hypothermia of 56 minutes, with an incidence of excessive
bleeding (which have justified the use of peri-aortic shunts
to the right atrium) in 40% of the patients [38] (C).
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Borst et al. [34] using hemi-arch repair or total arch
reconstruction techniques in 92 patients with aortic
dissection, have demonstrated that the mean CCA time
doubled and the mortality tripled using the second procedure
(17 minutes versus 34 minutes, and 12% versus 36%,
respectively). Similarly, Grawford et al. [33] studying 82
patients with type-A aortic dissections have reported a
significantly higher mortality rate in total replacement of the
arch (31%) than in intervention restricted to the ascending
aorta or the partial repair of the aortic arch (17%) (B).
These findings, as well as other reports [39,40], seem to
justify a careful approach of the aortic arch with preference
for the hemi-arch repair technique with an open
anastomosis, and the adjuvant use of biological adhesive
except for cases with much intra-arch destruction or
discontinuity of the descending portion of the thoracic
aorta (B); in these situations the best alternative appears
to be to implant a Dacron tubular graft in the descending
aorta, with the distal end without anastomosis (“elephant’s
trunk”) and the reimplantation of the supra-aortic branches
[41,42] (C). In a possible outcome, if it is necessary to repair
the descending aorta, the free end of the graft can be directly
anastomosed to the aortic wall or extended by means of an
additional tube to a more distal segments using left
thoracotomy. As a more simplified alternative it may be
valid to implant the covered stent to treat the descending
aorta by inserting it under direct visualization into the aortic
arch under the CCA [43] (C).
Among the methods described for cerebral protection
during interventions of the aortic arch (transverse arch),
the most used have been the CCA under deep hypothermia;
the hypothermic CCA with retrograde cerebral perfusion;
and the hypothermic CCA with anterograde cerebral
perfusion through the carotid artery or more recently,
through the subclavian-axillary axis.
Yet in the 1970s and 1980s, hypothermic CCA was
confirmed as the method of choice of cerebral protection
as it is easy to inspect the arch as for tunica intima injury, to
allow repair completely along its length, including the
proximal portion of the descending aorta and to avoid aorta
clamping near the arch from creating sites of dissection
near the distal anastomosis [30,37,38,44] (D). The technique
consists of establishing CPB by cannulization of the femoral
artery, on slow cooling up to 18 or 20º C (temperature at
which the metabolic rate is less than 18% of the normal), in
the use of iced bags for topical cooling of the head and
neck, and occasionally in the administration of CO2 in the
surgical area to reduce the risk of air embolism. Rewarming
must also be slow, somewhere close to 1º C each 3 minutes
to minimize hemolysis and the deleterious effects to
coagulation factors. Several groups have shown that
hypothermic CCA is effective and safe as for the
neurological morbidity, if the period of CCA is no more
than 45 minutes with a stroke rate between 3% and 12%
[34,37,45] (B). Even though, authors such as Ergin et al.
[46] report favorable outcomes with up to 60 minutes of
CCA and suggest that neurologic injury is more related to
the advanced age and preexistent cerebral atherosclerotic
disease than to the CCA itself (C).
However, sound data from Svensson et al. [47], in an
analysis of 656 cases of hypothermic CCA show a
significant increase of the postoperative stroke rate when
the CCA time exceeds 40 minutes, and an early mortality
with more than 60 minutes (B).
Recently, the control of the cerebral metabolic rate has
been proposed by measuring the oxygen saturation in the
jugular bulb as a parameter to start hypothermic CCA, but
its applicability and safety still need to be proved [48] (C).
The cerebral retrograde perfusion (CRP) through the
superior vena cava during CCA, first introduced by Ueda
et al. [49], has advantages of offering a sustained brain
cooling, eliminating metabolites resulting from ischemia,
removing the air or even debris with emboligenic potential,
as well as allow nutritional substrate infusion during CCA
(B). However, potential limitations such as
nonhomogeneous intracerebral distribution, presence of
valves in the jugular system [50] (C), cerebral edema [51]
(D), insufficient cerebral blood flow [52] (D), and bleeding
in the surgical area has made its use controvertible.
Coselli et al. [53] in a recent study of 479 cases of aortic
arch reconstructions, in which hypothermic CCA with CRP
was performed in 290 patients (60%) and isolated
hypothermic CCA in 189 (40%) demonstrated a significantly
lower in-hospital mortality in the group submitted to CRP
(3.4% versus 6.3%). As to the efficacy of the cerebral
protection, favorable findings of CRP were also described
by Safi et al., in a retrospective study of 161 patients
submitted to aortic arch surgery: protection effect against
stroke was three times higher when CRP was employed
(3% versus 9%), and this benefit was more obvious in
patients over the age of 70.  However, there was no
significant difference in the stroke or death rates among
the groups when the CCA time was less than 60 minutes. It
may be presumed that benefits of CRP were indeed involved
only using a profound hypothermia (B).
In a multicentric Japanese study, coordinated by Ueda
et al. [48], the results of 249 cases of aortic arch replacement
utilizing CRP, between 1994 and 1996, were analyzed. In
this study the mean CRP time was 46 minutes, the
postoperative stroke rate was 4%, and the in-hospital
mortality was l3%. A multivariable analysis identified
prolonged CPB time, the advanced age, and the urgency of
the surgery as the most significant risk factors related to
strokes or death (B).
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Another cerebral protection technique includes
anterograde perfusion during CRP, when cooled blood
infusion via the supra-aortic arteries (cerebroplegia) or
maintenance of perfusion by the axillary artery with clamping
of the brachiocephalic trunk can be used. In the technique
originally described by Guilmet et al. [55], the temperature
of the patient is kept at 25º C during CRP, part of the blood
of the oxygenator is cooled between 6 and 12º C and infused
directly into the carotid arteries at a rate of 200 to 250 mL/
min, at a pressure of 60 to 70 mmHg (C). Between 1984 and
1998 the authors used CCA and cerebroplegia in 171 cases
of aortic arch replacement, 42 of which due to type-A
dissections. In these cases the mean CPB time was 121
minutes, the mean selective cerebral perfusion time was 60
minutes, the in-hospital mortality was 17%, and the
occurrence of postoperative neurological damage was 13%
[56] (B). In Brazil, Souza et al., reported an experiment of
nine cases of aortic arch replacement using carotid arteries
selective perfusion without any event of postoperative
neurological deficit (C). Although other studies have also
suggested the superiority of anterograde perfusion over
CRP and hypothermic CCA both clinically [58] (C) and
experimentally [52] (D) complications, such as bleeding at
the site of cannulation and intra-cerebral bleeding have
restricted its use to only a few centers.
Cannulation of the axillary artery and the maintenance
of the flow through one of the carotid arteries during CCA,
as described by Sabik et al. [59], has the following
advantages: to avoid the handling of femoral artery, which
is often affected by dissections; to maintain the flow in the
anterograde direction through the true lumen (important
when the elephant trunk is used); and have no need of
deep hypothermia, which minimizes dyscrasic complications
(C). Additionally, problems of malperfusion of important
organs, and new reentry points are created by a pressure
increase in the false lumen are eliminated, as was
demonstrated by Van Arsdell et al. [60]. In this technique,
the axillary artery is dissected near the deltopectoral groove,
preferable to use the right side when possible, CPB is
maintained through the D axillary-atrial artery and the
temperature is maintained at approximately 24º C; once CCA
is established, the brachiocephalic (arterial) trunk
(innominate artery) is clamped at its root, and the flow is
reduced from 150 to 300 mL/min/m2 to reconstruct the arch.
According to a first positive experiment addressed to
small series [61, 62], the anterograde perfusion through
subclavian-axillary axis has been tested in more solid
studies. Svensson et al., comparing in-hospital outcomes
of 299 patients submitted to aortic arch reconstruction with
right axillary cannulation, to 471 cases of aortic perfusion
and 375 cases of femoral cannulation have observed
significantly lower death and cerebral infarct rates in the
first group (B). Similar result was observed by other authors
in studies case-control comparing both sites of axillary and
femoral cannulation [64-67] (B). Despite these evidences,
other authors point out the risks of severe complications
due to axillary cannulation, such as thrombosis and brachial
plexus injury [68] (C), but its efficacy still need to be proved
[69] (B).
Recommendations for surgical treatment of acute type-
A dissections are shown in Table 1.
Recommendation
Level
A
B
B
B
C
C
D
D
A
D
Table 1. Recommendations for the treatment of acute type-A
dissections
Recommendations
1. Immediate surgery to avoid rupture /
tamponing / death
2. Straight graft in the ascending aorta, if aortic
root and aortic valve are normal
3. Straight graft in the ascending aorta and aortic
valvar resuspension, if aortic root is normal
and the valve is insufficient due to loss of
support
4. Valved tube, if ascending aorta is dilated or
annulus/aorta suffers ectasia and aortic valve is
insufficient
5. Auto or homograft, if situation number 4 is
associated with endocarditis
6. Aortic valvar resuspension and remodeling
of the aortic root in Marfan’s syndrome
7. Partial repair of the aortic arch (hemi-arch
repair), if dissection involves the arch, but there
is no destruction or lesion to the tunica intima
8. Total reconstruction of the arch if it presents
with tunica intima destruction or injury
9. In case of aortic arch intervention, open
reconstruction using cerebral protection
(hypothermic CCA - cerebral retrograde
perfusion – cerebroplegia – axillary perfusion)
must be performed
10. Saphenous vein graft(s), if the openings of
coronary sinuses (coronary ostia) are affected
with delamination and the re-implantation is
not possible
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Acute Type-B Dissections
There is still general agreement that surgical treatment
of acute type-B dissections depends on the presence of
complications, such as signs of aortic rupture (hemothorax,
rapid expansion of the aortic diameter, mediastinal
widening), pseudoaneurysm formation, severe visceral
ischemia or ischemia of the extremities, or progression of
the dissection during drug therapy characterized by
persistent or recurrent pain. Also cases of previously
aneurysmatic aortas which are submitted to acute
dissection must be considered for urgent surgery.
However, groups such as the one from Stanford University
have demonstrated in a cohort of 136 patients with acute type-
B dissections, that a more aggressive approach might be
employed with young, low-operative risk patients using early
surgery without increasing in-hospital mortality (11%), when
compared to drug therapy, thereby avoiding chronic
aneurysmatic degeneration of the descending aorta [7] (C).
Even though these results were extremely favorable, they were
not considered reproducible by other centers. Indeed, the
International Registry of Acute Aortic Dissection [70], which
is considered to be an expression of the real world, reveals
that in cases of type-B dissections treated conservatively, the
mortality over 30 days was only 10%, while in the patients
surgically treated the mortality rate was 31% and the incidence
of paraplegia was 18%. After a three-year follow-up, there has
been no difference statically significant in the mortality rate
between the groups treated with drug, endovascular or surgical
therapies (B).
The surgical approach in descending aortic dissections
normally consists of the replacement of the affected portion
using a tubular Dacron graft by a left thoracotomy through
the 4th or 7th intercostal spaces, which can be performed
with simple proximal clamping [71] with atrial-femoral CPB
either with or without hypothermia [72, 73] (C), with femoro-
femoral CPB with cannulation, LA-femoral bypass without
using oxygenator [74] (B), temporary arterial bypasses or
even using CCA under deep hypothermia for a proximal
open anastomosis [75] (B). Depending on the chosen
technique, the dose of heparin and the effects of the
hypothermia level in the cascade of coagulation could
determinate variable effects on the hemostasis or in the
production of dyscrasia.
Another reported technique to repair type-B
dissections is the “elephant trunk” method, initially
proposed by Borst et al. [42] for staged surgical treatment
of complex aneurysms. After median sternotomy and
conventional CPB, hypothermic, CCA is induced and the
aortic arch (transverse arch) is opened lengthways; a
Dacron tubular graft is introduced into the proximal portion
of the descending aorta and anastomosed only in the
proximal segment after the left subclavian artery, with the
distal end continuing free in the thoracic aorta (C).
Subsequently, Palma et al. [76] also used this technique in
all cases of acute type-B dissections, in spite of the
existence of complications; the authors performed 70
consecutive insertions of the “elephant trunk” graft,
between 1988 and 1995 by median sternotomy with a short
period of hypothermic CCA (mean time of 31 minutes) and
presented a in-hospital mortality rate of 20% and an overall
survival over 5 years of 62% (C).
For the management of renal and mesenteric ischemia
or ischemia of the extremities, specifically when the origin
of these vessels is in the false lumen [77], it is generally
accepted that fenestration by catheter is the method of
choice (C), which is justified by the high mortality that
follows type-B aortic dissection surgery in these situations:
from 50 to 70% in the case of renal ischemia [78,79], 89% in
mesenteric ischemia [80, 82] (B),  and up to 87% in peripheral
ischemia [81] (C).
Since the first successes using fenestration by balloon
catheter to communicate false and true lumens in a case of
type-B aortic dissections with mesenteric ischemia, which
were described by Williams et al. [76] in 1990 (D), several
studies have tried to validate this approach [84-90] (D);
Additionally, the advent of aortic stents originally used to
exclude infra-renal abdominal aneurysms, provided a new
alternative in the management of complicated descending
aortic dissections.
In general, the branches affected by static obstructions
at their root are better treated by the intraluminal implantation
of stents, while vessels obstructed by dynamic
displacement of the blood column through a false lumen
may be reperfused by fenestration using a balloon catheter,
with or without stent implantation in the true lumen. In
other situations, stents can be used in the true lumen to
maintain the original position of some branches [89] (D), or
to maintain the fenestration open [91] (C). Another
indication for endovascular fenestration may be to create a
reentry in cases in which a “dead-end” false lumen
significantly compresses the true lumen, even though this
maneuver can increase the risk of peripheral embolization
[91] (D), [92] (C), or the long-term aneurysmatic dilations
maintaining the false lumen patent [93] (C).
The technical objective of fenestration is to create a
‘window’ between the false and true lumens, by “opening”
the tunica intima layer, normally near to the artery to be
saved; preferentially from the smallest lumen (generally the
true lumen) towards the biggest lumen (generally the false
lumen), using a special needle [91, 91] (D) and, if possible,
using vascular ultrasound (IVUS), followed by a 12- to 15-
mm balloon catheter, which is insufflated to promote
enlargement of the ‘window’ [86] (D). If necessary, a stent
of 10 to 14 mm can be implanted to avoid the possibility of
occlusion of the fenestration, due to a ‘flap’ mechanism or
thrombosis [91] (D).
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The results of reperfusion after percutaneous
fenestration of branches obstructed by aortic dissection,
even those reported from non-controlled studies [89-91]
(C) have been consistent: the flow restoration rate ranges
between 90 and 100%, the mean mortality rate over 30 days
is 10%, and no additional revascularization procedures were
necessary over an average 12-month follow-up.
Additionally, all deaths were related to the irreversibility of
the ischemia at the moment of the intervention, to the
progression of the dissection, or surgical complications of
combined interventions.
The implantation of coated endoprosthesis with tissues
in the descending aorta involves a greater diversity of
devices and techniques, being especially important the
margin of a healthy aorta in respect to the left subclavian
artery origin, the length of dissection, the existence of
reentry point(s) and the involvement of visceral trunks.
Usually, the diameter of the endoprosthesis estimated by
magnetic resonance, computed tomography,
transesophageal echocardiography or by IVUS, ranges from
24 to 42 mm, in general being 10 to 15% larger the aorta
diameter, being the length or even the use of more than one
device decided according to the length of the aorta injury
to be coated. Depending on the proximity of the visceral
branches, one part of the prosthesis should not be coated
to maintain the patency of the openings (ostia) involved.
Occasionally, the carotid-subclavian bypass can be
previously manufactured in cases in which the proximity of
the left subclavian artery opening can determine its
obstruction. The right femoral artery is the commonest
insertion site with the positioning of the endoprosthesis
being guided by angiography, IVUS or both methods.
Arterial pressure monitoring is important during
implantation, normally tending to increase during the
expansion of the devices and to decrease significantly after
its placement. It is recommended to keep the mean arterial
pressure between 50 and 60 mmHg, which requires the
application of sodium nitroprusside [23] (D).
Preliminary results indicate that the use of stents in
complicated type-B dissections is more reliable and causes
a smaller risk implanted percutaneously when compared to
the implantation by open surgery [95] (C), and that the
incidence of paraplegia may be significant with the use of
prostheses longer than 15 cm [95,96] (D).
Thus, when it is necessary to treat longer segments of
the aorta as in case(s) of distal reentry(ies), it is preferable
to use multiple shorter prostheses, which has the additional
advantage of better modeling in cases of aortae that present
with much curvature. It may also be useful to perform hybrid
surgeries, such as the carotid-subclavian bypass before
implantation in many cases where the treated portion is
very close to the emergence of the left subclavian artery, a
maneuver, which in the experience of Grabenwöger et al.
[97], is employed in nearly 40% of patients (C). The short-
term follow-up has demonstrated that the obliteration of
the tunica intima injury remains and the aortic diameter is
reduced with the thrombosis of the false lumen; in cases in
which periprosthetic leaks are discovered and in those in
which reentries not seen in the first diagnosis are identified,
the treatment, in general, may be the implantation of another
stent [98] (C).
Recently, in Brazil, an expressive contribution has been
proposed by the group of the Escola Paulista de Medicina,
(Paulista Medical School) by using percutaneous self-
expanding stents in all cases of descending aorta
dissections. Palma et al. [99] submitted 70 patients with
type-B dissections (60% of which were true dissections
and 40% corresponded to intramural hematomas or
penetrating ulcers) to implantation via femoral artery of
polyester-covered endoprostheses (Braile Biomedica®),
under general anesthesia, systemic heparinization, and
induced hypotension. The procedure was considered to
be a success in 65 (93%) patients with the exclusion of the
false lumen documented using aortography. In 5 cases (7%)
conversion to surgery was necessary; there were no events
of paraplegia or death. In a mean follow-up of 29 months
(from 1 to 55 months), 91% of the patients were alive but
the insertion of additional stents was required in 49% of
the cases (C). In a more recent report on this series [100]
with 120 cases of type-B dissections, the results were
consistent: the in-hospital mortality was 10%, surgical
conversion occurred in 6 (5%) cases, there were no cases
of paraplegia (even though 2/3 of the descending aorta
were excluded in 38 cases and the treated region was
between T9 and T12 in 34 patients) and the long-term
survival rate was 87%. The necessity of implantation of
additional stents occurred in 51% of the series, in 14 patients
the left subclavian artery was intentionally occluded using
an endoprosthesis and in only one case, a carotid-
subclavian surgical shunt was necessary (C).
The death of the patients submitted to surgery with
complicated type-B dissection was 29.3% according to the
international Registry of Acute Aortic Dissection (IRAD)
[101], and the clinical preoperative conditions have had
significant influence in the treatment outcome (B).
A recent meta-analysis [102] has shown that the
endovascular treatment in type-B dissections is technically
viable with success rates higher than 95% in selected
cohorts. Although the technique is invasive, the
complications have occurred between 14% and 18% of the
patients with a much lower incidence of paraplegia. The
short- and medium-term mortality rates of this new approach
can be favorably compared to the conventional surgery
(A). Further studies will be necessary to compare the
endoprostheses to medical treatment in uncomplicated type-
B dissection.
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In summary, there are not doubts about the benefits of
percutaneous intervention techniques in the management
of complications involving the acute descending aortic
dissections when compared to conventional surgery. Even
so, issues such as whether the endovascular technique
will replace the initial drug therapy in uncomplicated cases,
as well as the role of endoprostheses implantation in the
descending aorta during ascending aorta surgeries remain
unclear, in spite of the preliminary promising results.
Table 2 summarizes the recommendations and forms of
interventions in acute type-B dissections.
the long-term survival rate: two out of 18 cases (11%) of
patent false lumen needed interventions and the event-
free survival rate over 5 years was 83% for false lumen with
thrombosis, and 64% in cases of patent false lumen (B).
The patency of the false lumen after aortic dissection
surgery seems to be more related to the high frequency of
distal reentries than to the success of the exclusion of the
initial injury site, what reinforces the necessity of a follow-
up with extremely rigorous clinical control, in particular in
respect to systemic arterial hypertension (SAH) and imaging
method in the 1st, 3rd, 6th and 12th post-procedure months
and thereafter annually [23] (D).
There are evidences that the method of choice for long-
term monitoring and occasional indication of intervention
should be the nuclear magnetic resonance (NMR) because
it avoids exposure to radiation or to nephrotoxic contrasts
used in computed tomography (CT) and is less invasive
than transesophageal echocardiogram (TEE); a comparison
of serial images facilitates the early detection of increases
in the false lumen or the entire aorta, and can be hold
responsible for the possible identification of the important
visceral branches and their relationships to the dilated
portion [109] (C), [110] (B), and [23] (D).
There is clear consensus that the aggressive
management of SAH with negative inotropic agents is the
most important independent factor in the prevention of
chronic aneurysmatic degeneration or rupture; although
the use of beta-blockers are the first-line therapy of choice
because they decrease the dp/dt, in general, the association
of more than one drug is required [23] (D). As was
demonstrated by DeBakey et al. [111] in 527 patients after
acute aortic dissection, aneurysms developed in 46% of
the cases with uncontrolled arterial pressure, but only in
17% of normotensive patients (B).
Of all the cases of death in the experience of Stanford
University [112], at least 15% occurred due to aortic rupture,
while a 20-year follow-up performed by Baylor College of
Medicine [111] revealed that 30% of late deaths were due
to the rupture of chronic aneurysms. In fact, it is estimated
that about 30% of the surgical cases operated due to acute
aortic dissection will suffer aneurysmatic degeneration,
more frequently on the thoracoabdominal axis (35%),
followed by proximal descending aorta (16%), and ascending
aorta (14%) [113] (B). Similar data were published in Europe,
where a survival rate of 70 to 85% is reported in the first
year and 60% over two years in cases of type-B dissections,
with the best prognosis in cases with non-communicant
false lumens (80% of survival over 2 years) [105] (B).
Patients with Marfan’s syndrome must adhere to a
stricter familiar follow-up to anticipate catastrophic events
or delayed recurrences, although cases of multiple
interventions are not rare [114, 115] (B); Thus, the
recommendation to intervene in aneurysmatic dilation of
Recommendations
1. Clinical management with analgesics and
aggressive control of the arterial pressure
2. Surgical treatment, if persistent/recurrent pain,
signs of expansion, rupture or bad perfusion of
the extremities
3. Implantation of covered endoprostesis, if
persistent/recurrent pain, signs of expansion,
rupture or bad perfusion of the extremities and
appropriated anatomy
4. Stent to unblock the visceral branch root, or
to maintain the fenestration open
5. Fenestration by balloon and stent
implantation, if there is severe compression of
the true lumen, with or without distal reentry
6. Implantation of covered endoprostesis in true
lumen to avoid chronic aneurysmatic dilation of
aorta
7. Implantation of covered endoprosthesis in
true lumen to occlude the tunica intima injury
and to promote thrombosis of the false lumen
Table 2. Recommendations for the treatment of acute type-B
dissections
Recommendation
Level
A
A
A
C
C
C
C
The long-term follow-up of patients with acute aortic
dissections, operated or treated using conservative
methods in the acute phase demonstrates that the false
lumen remains patent in about 80% of the cases [103] (D);
additionally, it is known that in only 10% of patients
operated by De Bakey dissections type I, the false lumen
remains obliterated [104-107] (B). However, this patency
should not be seen as an imminent catastrophic event and
often it may be the main source of blood of some noble
organs [103] (C). In the experience of the Mount Sinai
Medical Center [108], the persistence of a false lumen was
associated with a low incidence of aneurysmatic
degeneration and no significant differences were seen in
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the thoracic aorta or in an annulus-aortic ectasia, in this
specific group, follows earlier criteria that shall be
commented in the following topic, although the definitive
cutoff point should have been defined in yet unavailable
longitudinal studies, which would determine the normal
diameter of the aortic root in young patients with Marfan’s
syndrome [116, 117] (D). A moderate restriction of physical
exercise also seems to be beneficial in children and young
adults, because of the potential association of hypertension
and rupture induced by exercise [118] (D).
Information about the natural history of intramural
hematomas (IMH) is limited and sometimes contradictory
in the literature. Generally, this can be considered a
condition as potentially catastrophic as acute aortic
dissections concluding that the mortality rate is significant
– from 20 to 80% [119] (B) [120] (C); the evolution to true
dissections occurs in 15 of 41% of the cases [121-124] (B),
ruptures in 5% to 26% of the patients and evolution to
spontaneous cure varies [125] (A) [126] (B).  In a recent
prospective survey of 360 cases of acute aortic dissections,
Nienaber et al. [121] observed that 25 (12%) cases presented
evident false lumen, but without identified tunica intima
injury in the diagnostic examinations. The mortality in 30
days when there was involvement of the ascending aorta
was 80% in clinically treated cases and zero in operated
patients, similar to the type-A aortic dissection (B). Vilacosta
et al. [126] analyzed the evolution of 21 cases of IMH, of
which 15 were spontaneous – 8 involving the ascending
aorta and 7 confined to the descending portion – and 6
were caused by trauma. In the group considered type-A, 3
(37%) cases evolved to sudden death, 3 (37%) were
successfully operated, and 2 (25%) evolved to a cure. In
the type-B group 1 (15%) sudden death occurred and 6
(85%) had favorable clinical courses by drug therapy, while
in the trauma group there were spontaneous cures in 3
(50%) patients, and other 3 cases (50%) in this group
evolved to death, but due to causes not related to ruptures.
Even though the sample was small, the authors suggest
that the natural history of IMH is better in trauma or cases
restricted to the descending aorta than cases that involve
the ascending aorta (C).
The evolution of ulcerated aortic plaque is also not
completely known and controversial, in the few reports
available. While some authors consider that it is as
dangerous as true acute aortic dissections with a high
possibility of rupture, others point out its benign clinical
course that does not require immediate surgical treatment
[127, 128] (C). However, the existence of sub-intimal
hematomas or penetrating ulcers should be viewed as
possible imminent ruptures. In a retrospective survey of
198 aortic dissection cases, the group from Yale University
[129] detected the presence of 15 penetrating ulcers (8%)
identified in imaging examinations prior to the acute event,
of which 13 (87%) were found in the descending aorta. The
mean age and the size of the aorta in this group were
significantly higher than in the overall sample and an
association with infra-renal abdominal aortic aneurysms
was seen in 40% of these patients, with ruptures seen in
the hospital evolution in approximately 40% of the cases
(C). The development of pseudoaneurysms in these
ulcerated plaques is another long-term complication
observed [130, 131] with the development of true
dissections estimated from 10% to 20% of the cases (C).
The recommendations for the long-term follow-up of
patients after suffering from acute aortic dissections are
illustrated in Table 3.
Table 3. Recommendations to the follow-up of patients with
aortic dissection
Recommendation
Level
A
D
D
Recommendations
1. Continuous control of systemic arterial
hypertension with beta-blockers
2. Imaging examinations (NMR, CT etc)
3. Moderate restriction of physical exercises
CHRONIC DISSECTIONS – THORACIC ANEURYSMS
Ascending Aorta - Aortic Arch
The aorta is considered pathologically dilated when its
diameter exceeds the normal for a specific age and body
surface area. When the diameter is more than 50% of the
expected size, the segment is considered aneurysmal.
In the ascending aorta, the progressive dilation can lead
to aortic valve insufficiency (even in anatomically normal
valves), acute dissection or spontaneous rupture. These
are events which dramatically change the natural history
and the survival curve with the amount of risk being related
to the diameter and to the type of structural disease of the
aortic wall.
Indications for the surgical replacement of the ascending
aorta in patients with Marfan’s syndrome, acute dissections,
intramural hematomas or endocarditis with extensive
annular damage are supported by consistent evidence.
However, the moment of the intervention in asymptomatic
patients with degenerative dilations, as well as in the
association of dilation of the aorta with the bicuspid aortic
valve remain uncertain.
In Marfan’s syndrome, there is an agreement that
prophylactic surgical repair is indicated when the diameter
reaches 5.5 cm, although it may be smaller (4.5 to 5 cm) in
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patients with familiar history of dissections, ruptures or
sudden death [116, 132-136] (B). In the other cases, although
the presence of symptoms or the severity of aortic
insufficiency can indicate intervention independent of the
aortic size, it is generally accepted that a diameter of 6 cm is
indicative of surgery in asymptomatic aneurysms [137] (A).
Therefore, groups such as that of the Mount Sinai Medical
Center based in its recent experience have proposed
differentiated criteria for intervention, such as diameters of
4.3 cm in under 40-year-old adults with Marfan’s syndrome
ranging from 4.8 to 5 cm in cases found by chance during
heart surgery for different diseases and 4.5 cm in surgeries
of bicuspid aortic valves [16] (B).
The aortic root and/or descending aorta surgical
reconstruction options have already been described
previously, but in cases of chronic aneurysms, some aspects
can contribute to the choice of the technique:
• Age and life expectation in very old or high surgical
risk patients, valve replacement and the reduction in the
aorta diamentera by a lengthways suture with support may
be a good alternative [138] (C); likewise, valve replacement
followed by the implantation of a Dacron straight graft,
separately, can be appropriate for patients with limited life
expectation [139] (B).
• Quality of aortic wall: a weakened aorta as in acute
dissections or in Marfan’s syndrome generally requires removal
of all friable tissue of the aortic root and the ascending portion;
in these cases, the Bentall button technique can be useful [14]
(B) or valve remodeling [140] (C).
• Anatomy of the aortic valvar apparatus – aortic sinuses
(sinuses of Valsalva) - Sinotubular portion: when there is
dilation of the apparatus, valved tube implantation or
exceptionally auto/homografts. If the valve is normal but
there is dilation of the sinuses or of sinotubular region,
valve remodeling techniques as suggested by Tirone David
can be employed [23] (D).
• Anticoagulation risks: in patients at considerable risk
of bleeding, the remodeling techniques or auto/homografts
must be given preference [23] (D).
• Association with aortic valvar endocarditis: although
there is no conclusive evidence, the majority of groups
recommend auto or homografts in this situation [23] (D).
Using this systematization, Mount Sinai Medical Center
group has recently published their experience of 497 cases
of annulus-aortic or ascending aorta reconstruction,
specially in elective surgeries (n=310), corrected using the
Bentall button technique (n= 250). The overall in-hospital
mortality was 8%, and when excluding urgent surgeries
5.5%; in the 250 cases of the modified Bentall technique
the hospital mortality was only 4%, and the reoperation-
free survival rate was 79% over 5 years, and 62% over 8
years, results that substantiate the authors recommendation
of this technique [16] (B).
In respect to aneurysms located in the aortic arch
(transverse arch) the currently accepted indications for
surgical resection include: 1) an absolute diameter > 6 or 7
cm, or greater than two times the expected diameter for that
patient; 2) growth in the diameter greater than 7 or 10 mm
per year; 3) pain or symptoms of compression; and 4)
saccular aneurysms [141] (B). Patients with Marfan’s
syndrome generally are indicated for earlier surgery, with
growth greater than 3 to 5 mm per year, or absolute diameters
of 5 cm [142] (D). Technical details referring to the surgical
repair methods and cerebral protection described in acute
dissections involving the transverse arch are applicable
here too.
Descending Aorta – Thoracic-abdominal
In asymptomatic patients with descending aorta
aneurysms (DAA) or thoracicoabdominal aorta
aneurysms (TAAA), the identification of predictors of
dissection, rupture and/or death have been exhaustively
studied, attempting to establish a safe cutoff point to
indicate surgery, as the mortality and the operative
morbidity rates are significantly higher than in ascending
aortic surgery. Thus, some complicated exponential
equations have been proposed to calculate an estimate
of acute events in cases of DAA [143,144] (B). However,
the group from Yale University has performed consistent
and simplified studies [141, 145] pointing out the diameter
as the most relevant independent risk factor for
complications. Based on a database of 721 patients with
DAA, the authors followed the evolution of 304
asymptomatic cases with a minimum diameter of 3.5 cm
and clearly demonstrated that the incidence of
associated complications – rupture, dissection or death
– was 15.6% for aneurysms with diameters of 5 to 6 cm
and only 3.9% for diameters between 4.0 and 4.9 cm
(p=0.004). When the rupture were analyzed separately,
the Odds ratio (OD) increased 27 times when the diameter
reached 6 cm when compared to cases of 4.0 cm or less
(p=0.002). Additionally, the 5-year survival curve of
patients with diameters > 6 cm was only 56%, and 85%
for elective operations (p=0.003) similar survival to that
found in the normal population with the same mean age
(B). These findings associated with operative mortality
of 11% presented by the group have led the authors to
choose 6 cm as the parameter for the surgical indication
of DAA, a conduct considered consensual by specialists
[23] (D).
The principal concern in the surgical repair of descending
or thoracicoabdominal aneurysms is still paraplegia, with a
reported incidence at between 4 and 32% in recent works
[146-157] (B). Indeed, medullar injury still is a devastating
event for the patient, family and surgical staff. Although
paraplegia is clearly multifactorial, it occurs due to one or
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more of the following conditions: 1) duration and degree of
medullar ischemia; 2) failure to reestablish the blood flow
to the spinal column after repair and 3) biochemical-mediated
reperfusion injury.
To reduce medullar ischemia, many techniques have
been recommended, with conflicting clinical results.
When no method of distal perfusion is used during the
reconstruction, the aorta should only be clamped proximally,
as recommended by Crawford et al. [158], to avoid increases
in the CSF pressure, sequentially repositioning the clamping
cephalocaudally as the reconstruction proceed forward and
the main intercostal branches, and the visceral branches
are anastomosed into the prosthesis. While ischemia times
of less than 30 minutes are relative safe, this approach
presents an unacceptable incidence of paraparesis or
paraplegia with times greater than 60 minutes (B). In contrast,
when distal perfusion is maintained to optimize the nutrition
of the intercostal and lumbar arteries, short periods of
sequential ischemia can be performed; in this technique,
CPB is established by left atrium-femoral or femur-femoral
vessels which allows the maintenance of perfusion up to
the T5 or T6 level during the first clamping of the proximal
aorta and of the left subclavian artery. Once the proximal
anastomosis is concluded, the distal clamp is usually placed
just above the celiac trunk and the main intercostal vessels
are included in the graft. In the next step, the clamp of the
prosthesis is placed below the intercostal arteries, and the
distal aorta clamp below the renal arteries, which are included
as a block or individually. Subsequently, the aortic clamping
is transferred to the infra-renal portion and the distal repair
is concluded. With this approach of sequential ischemia
there has been a significant reduction in the rates of
paraplegia and renal insufficiency [71] (B).
Other methods of distal protection may include CPB
with hypothermic cardiocirculatory arrest or the use of both
temporary internal or external shunts. While Kouchoukos
et al. [75] supported by incidences of 6.5% for paraplegia
and 10% for death over 30 days recommended total CPB
with CCA under deep hypothermia, Crawford et al. [159]
considered this technique particularly useful in aneurysms
that involve part of the arch or in arches extensively calcified
in their proximal portions, presenting paraplegia and
mortality rates of 9.5% and 16%, respectively (B).
Alternatively, several types of temporary shunts have
been proposed justified by the necessity of smaller doses
of heparin and because they do not exclude hypothermia,
thereby minimizing bleeding complications. The greatest
experience in the literature was published by Verdant et al.
[160] who used aorto-aortic or aorto-femoral bypasses in
366 consecutive cases of DAA with a in-hospital mortality
of 12% and no cases of paraplegia; however and curiously,
even with these highly positive results, the authors now
recommend atrio-femoral CPB due to the significant
incidence of strokes and aortic injuries at the sites of the
shunts, besides the inappropriate control of both the flow
and the distal perfusion pressure (B).
Drainage of cerebrospinal liquid (CSF) to reduce the
intrathecal pressure constitutes another form of medullar
protection, widely tested in several animal models,
associated or not with infusion of neurotropic-negative
drugs [161-166] (C) [167] (D).
Preliminary studies performed in the Mayo Clinic were
favorable to the protective effect of CSF drainage, but the
subsequent results did not demonstrate significant benefits
[168] (C). Other groups have advocated CSF drainage
associated with the local infusion of naloxone [149] (C) or
during atriofemoral CPB [169] (B).
Although Acher et al. [143] in a non-controlled study
have suggested that naloxone associated with CRL drainage
can even rule out the re-implantation of intercostal arteries
(C), no benefits of this technique were evidenced in
subsequent randomized trials [170] making its use empirical
(A).
The effect of epidural administration of papaverine on
the function of spinal cord has been referred to as having a
promising effect. In experimental models of thoracic aorta
clamping for up to 60 minutes at normothermia, an
intrathecal injection of papaverine was highly effective in
preventing paraplegia, demonstrating a significant increase
in the blood supply in the anterior portion of the spinal
medulla by the use of radionuclides [164] (D).
At a clinical level, the removal of a small volume of CSF
followed by the intrathecal application of papaverine also
showed potential benefits in some non-controlled
prospective studies [171] (B).
Other pharmacological agents proposed as adjuvants
in the prevention of paraplegia include corticosteroids [150]
(C), mannitol [172] (C), magnesium sulphate [166] (C),
prostaglandins [173] (C), allopurinol [174] (C), and
flunarizine [175] (D) among others, but none has proved to
be effective in the clinical practice.
A consensual recommendation discusses the necessity
of re-implantation of the maximum number of main
intercostal arteries, particularly in the lower 1/3 of the thorax
and upper abdomen between T7 and L1 [176] (D). Several
studies have already demonstrated that the blood supply
to the spinal cord at the thoracic level is predominantly
supplied by the intercostal arteries between T4 and T12
and by the lumbar arteries between L1 and L4 [177] (A),
[178] (D), and [179] (C), and that between T7 and L1, in
more than 90% of patients emerge the most important
anterior radicular artery, referred to as the Adamkiewicz
artery. Even though, in chronic processes such as
atherosclerotic aneurysms there can be development of
collateral circulation capable of maintaining the medullar
functioning even when there is extensive sacrifice of
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intercostal branches, or when early thrombosis of some
intercostal patchs is an arteriographically documented
event [180] (C), all the effort must be made to protect these
vessels. Thus, the preservation of the posterior wall of the
terminal thoracic aorta as proposed by Williams [181] can
be a valid maneuver (C).
Due to the diversity of anatomic variations in the
medullar blood supply that can include from a well-
developed and easily identified anterior radicular artery, or
many large caliber terminal intercostal arteries, or even many
small caliber arterioles, intraoperative mapping models of
the segmental arteries have been tested, aiming at selecting
arteries to be re-implanted reducing the aortic clamping
time, such as the intraoperative infusion of hydrogen to
identify intercostal branches that effectively contribute to
medullar perfusion [182] (C).
Similarly, many experimental and clinical studies [183-
188] have been developed trying to define the role of the
motor-evoked or somatosensorial potentials in monitoring
the activity of the segmental medulla and in the prevention
of the paraplegia; although with very variable results and
with recommendations still not consensual in respect to
the efficacy as an isolated method in the prevention of
medullar ischemia (C).
Crawford et al. [177] prospectively analyzed the role of
the somatosensory evoked potentials (SSEPs) in a
randomized trial of 198 patients submitted to DAA or
thoracoabdominal aortic aneurysms (TAAA) correction. As
not only did monitoring SSEP not demonstrate a protecting
neurological effect, there were incidences of 13% false-
negative and 67% false-positive cases in the responses of
the monitored group leading the authors to believe that
there is no sustenance for this technique (A).
As mentioned in the section about acute dissections,
an innovative and highly promising approach in the
treatment of DAA is the implantation of self-expanding
stents, developed by the Stanford University group.
Preliminarily, the authors used the percutaneous
implantation of self-expanding stents covered by Dacron
in the femoral artery in 13 cases of chronic thoracic
aneurysms with a mean diameter of 6.1 cm. An immediate
exclusion was observed in 12 patients and no deaths or
cases of paraplegia in the hospital phase were reported,
and not even over a mean follow-up period of 11.6 months
[189] (C). In a clinical assay developed subsequently [190],
the same authors amplified the experiment to 103
implantations, the majority of which had prohibitive surgical
risk, and obtained immediate success rates of 83%. The
early mortality was 9%, paraplegia was observed in 3% of
the patients, and 7% developed ischemic strokes during
the hospital stay. The long-term follow-up of 3.7 years has
demonstrated an event-free survival rate of 53%, and the
group started to recommend this technique for selected
high operative risk patients (A). However, the greatest
experience with the percutaneous exclusion of DAA was
published recently by Buffolo et al. [100]. Between 1996
and 2002, 191 stent implantations were performed in cases
of type-B dissections (n=120), true thoracic aneurysms
(n=61), deep ulcer hematomas (n=6) and trauma of the
descending aorta (n=4). In all patients the authors used
general anesthesia, induced hypotension (mean arterial
pressure between 50 and 60 mmHg), heparinization only
during the procedure (5000 IU/IV), and polyester-covered
stents (Braile Biomédica ®), the sizes of which were
calculated as 10% to 20% bigger than the diameter of the
aorta. The success rate of the implantation, defined as the
obliteration of the tunica intima laceration, or the complete
exclusion of the aneurysms without extravasation was 91%,
the in-hospital mortality was 10%, conversion to surgery
was necessary in 6 cases (3%), and no cases of paraplegia
were observed (C).
In a multicentric clinical assay [191] the early outcomes
of the endovascular treatment were better than the surgical
outcomes: mortality rate 2.1% (endovascular) vs 11.7
(conventional surgery) – p < 0.001, even in low risk patients
(A). Nevertheless, in the same study, in a 2-year follow-up
there were a considerable incidence of leaks (endoleaks)
and re-interventions in the endoprosthesis group. It is
recommended the continued follow-up of these patients.
Undoubtedly, these results may represent the most
important advance in the treatment of a cardiovascular
disease which has extremely high morbidity and mortality
rates and is one of the most challenging for surgeons.
Table 4 presents recommendations for the management
of chronic aneurysms of the thoracic aorta.
Recommendation
Level
A
D
A
A
Table 4. Recommendations for the surgical treatment of chronic
thoracic aorta/ thoracic-abdominal aneurysms
Recommendations
Ascending aorta
1. Surgery, if there are compression symptoms,
aortic insufficiency or aortic diameter > 6.0 cm
2. In Marfan’s syndrome, prophylactic surgery
if diameter > 5.5 cm or > 5.0 cm in cases with
familiar history of dissection or sudden death
Descending aorta
1. Surgery, if symptoms or aortic diameter >
6.0 cm
2. Stent implantation, if aortic diameter > 6.0
cm and favorable anatomy
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Abdominal Infra-renal Aorta
In few situations in medicine, a surgical intervention
called “prophylactic” have had such a great impact in the
modification of the natural history of a disease, as in the
case of infra-renal abdominal aneurysms (AAA), not only
due to its high prevalence (from 90% to 95% of all cases of
aortic aneurysms), but also due to the increase in morbidity
and mortality that follow its emergency repair (the mortality
risk is 10 times greater than in elective surgeries). To
establish guidelines for the indication of elective repair of
AAAs, aiming at corroborating the decision making, some
aspects about the pattern of this disease must be
considered:
• Abdominal aneurysms are often found by chance,
mainly in elderly people. Many studies have estimated that
AAA are found in 2% of people aged between 60 to 69
years, and in approximately 5% of people over 70-year-
olds, being 2 to 3 times more common in men than in woman
[192, 193] (B).
• The association of AAA with some diseases is well-
known and relatively predictable: it is known that AAA is
found in about 5% of patients with coronary atherosclerosis
[194] (A), 9% of peripheral artery disease cases [195] (A),
and in 30% to 50% of the patients with popliteal or femoral
aneurysms [196] (B).
• AAAs are easily detectable by clinical examination
and by non-invasive diagnostic methods. In general, an
experienced physician can detect aneurysms of 5 cm in
diameter directly by palpation, but the precision of the
diagnosis only by touch is < 50%, while ultrasound is
able to diagnose AAAs of any diameter in 100% of cases
[192] (B).
• Ruptures of AAAs are considered a serious public
health problem. It is estimated at 15,000 deaths per year in
the USA the cases that reach hospital and maybe two or
three times this number if all cases of sudden death by
AAA that occur out of the hospital are included [197] (B).
• Ruptures of AAAs are no longer related to large, rapid
growth aneurysms, or to the early onset of symptoms. The
risk of rupture over 5 years for aneurysms smaller than 5 cm
in diameter is estimated as less than 5%, while in aneurysms
larger than 5 cm, the accumulated risk is 25% to 43% [197,
198] (B), [199] (D). A multivariate analysis of some studies
have identified rapid expansion and the presence of
significant abdominal, or low back pain as the most
important predictors for rupture, independently of the size
of the AAA [200] (A), [201] (B).
• Small aneurysms grow at a variable speed: although it
is estimated that the mean expansion of AAAs must be
about 0.4 cm/year, there is a great variability making
impossible to predict the evolution in a specific patient
[200] (A).
• The risk of death or major complications with elective
surgery of AAA is dependent on the experience of the
surgical group and on the numbers of surgeries in the
hospital, but currently the mortality rate must be lower
than 5%. Although meta-analysis of recent studies point
to a mean mortality rate up to 3.5% [202-206] (B), a variation
up to 10% is observed between surgeons and institutions
[207] (B).
The presence of symptoms in AAAs is a consensual
surgical indication independent of the diameter. These
symptoms include pain/lumbar or abdominal discomfort,
distal embolization or signs of compression of neighboring
structures. Obviously, emergency surgery is essential in
the cases when rupture is suspected.
Also aneurysms of an inflammatory etiology are
indicative of elective repair independent of the size, as they
are followed by significant systemic manifestations, such
as fever and weight loss [193] (D).
For asymptomatic patients, the indication of intervention
must consider the risk of rupture versus the individual
operative risk and the life expectancy. In the 90s, the
International Society for Vascular Surgery recommended
elective surgeries for AAAs with diameter exceeds 5.0 cm,
or even 4.0 cm in patients with chronic obstructive
bronchopulmonary disease based on the low postoperative
mortality rate found in this group (1%). Also, there was a
clear recommendation to contraindicate the surgical repair
of AAAs of any size when metastatic neoplasias, severe
heart failure, or other conditions that limit survival to no
more than 2 to 3 years [199] (D).
However, the results of 2 recent large clinical trials may
modify these criteria.
In the United Kingdom Small Aneurysm Trial [208], 1090
patients with asymptomatic aneurysms with diameters
between 4.0 and 5.5 cm were randomized for conservative
treatment with serial ultrasound examinations or elective
surgical repair and follow-up over a period of from 6 to 10
years (mean: 8 years). The surgical mortality rate was 5.5%
and survival over 8 years was similar in both groups,
although slightly better in the intervention group after this
period. No differences were observed in this pattern in
respect to age, gender, or the initial size of the aneurysm
and the authors concluded that asymptomatic AAAs
patients with diameters up to 5.0 cm can be conservatively
followed-up without additional risks (A).
The findings were also confirmed in the Aneurysm
Detection and Management Veterans Affairs Cooperative
Study [209], in which 1136 patients with infra-renal
aneurysms with diameters between 4.0 and 5.4 cm were
randomized for surgical treatment (n=569) or for periodic
echographic control (n=567). The in-hospital mortality in
the operated group was 2.7% and there was no difference
in the 5-year survival rate between the two groups. There
was no reduction in the death rate related to complications
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